Annual gross profit:
$2.57B+$497.70M(+24.04%)Summary
- As of today (April 25, 2025), UTHR annual gross profit is $2.57 billion, with the most recent change of +$497.70 million (+24.04%) on December 31, 2024.
- During the last 3 years, UTHR annual gross profit has risen by +$1.00 billion (+64.28%).
- UTHR annual gross profit is now at all-time high.
Performance
UTHR Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$660.00M-$5.80M(-0.87%)Summary
- As of today (April 25, 2025), UTHR quarterly gross profit is $660.00 million, with the most recent change of -$5.80 million (-0.87%) on December 31, 2024.
- Over the past year, UTHR quarterly gross profit has increased by +$116.30 million (+21.39%).
- UTHR quarterly gross profit is now -0.87% below its all-time high of $665.80 million, reached on September 30, 2024.
Performance
UTHR quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$2.57B+$116.30M(+4.74%)Summary
- As of today (April 25, 2025), UTHR TTM gross profit is $2.57 billion, with the most recent change of +$116.30 million (+4.74%) on December 31, 2024.
- Over the past year, UTHR TTM gross profit has increased by +$497.70 million (+24.04%).
- UTHR TTM gross profit is now at all-time high.
Performance
UTHR TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
UTHR Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.0% | +21.4% | +24.0% |
| 3 y3 years | +64.3% | +22.4% | +31.1% |
| 5 y5 years | +92.9% | +98.3% | +93.0% |
UTHR Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.3% | -0.9% | +52.5% | at high | +56.3% |
| 5 y | 5-year | at high | +92.9% | -0.9% | +98.3% | at high | +96.4% |
| alltime | all time | at high | >+9999.0% | -0.9% | >+9999.0% | at high | >+9999.0% |
United Therapeutics Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $2.57B(+24.0%) | $660.00M(-0.9%) | $2.57B(+4.7%) |
| Sep 2024 | - | $665.80M(+4.5%) | $2.45B(+5.4%) |
| Jun 2024 | - | $637.10M(+5.3%) | $2.32B(+4.7%) |
| Mar 2024 | - | $604.80M(+11.2%) | $2.22B(+7.3%) |
| Dec 2023 | $2.07B(+16.0%) | $543.70M(+0.8%) | $2.07B(+5.7%) |
| Sep 2023 | - | $539.30M(+1.3%) | $1.96B(+3.2%) |
| Jun 2023 | - | $532.40M(+17.1%) | $1.90B(+5.3%) |
| Mar 2023 | - | $454.60M(+5.1%) | $1.80B(+1.0%) |
| Dec 2022 | $1.78B(+14.2%) | $432.70M(-9.6%) | $1.78B(+3.0%) |
| Sep 2022 | - | $478.80M(+9.5%) | $1.73B(+3.7%) |
| Jun 2022 | - | $437.20M(+0.3%) | $1.67B(+1.7%) |
| Mar 2022 | - | $436.00M(+14.6%) | $1.64B(+5.1%) |
| Dec 2021 | $1.56B(+13.7%) | $380.60M(-8.7%) | $1.56B(+2.0%) |
| Sep 2021 | - | $417.00M(+1.9%) | $1.53B(+4.1%) |
| Jun 2021 | - | $409.30M(+14.9%) | $1.47B(+5.2%) |
| Mar 2021 | - | $356.10M(+1.7%) | $1.40B(+1.7%) |
| Dec 2020 | $1.38B(+3.3%) | $350.10M(-1.7%) | $1.38B(+5.2%) |
| Sep 2020 | - | $356.10M(+6.0%) | $1.31B(-0.9%) |
| Jun 2020 | - | $336.10M(+1.0%) | $1.32B(-0.8%) |
| Mar 2020 | - | $332.90M(+17.9%) | $1.33B(-0.0%) |
| Dec 2019 | $1.33B(-6.9%) | $282.30M(-23.4%) | $1.33B(-4.8%) |
| Sep 2019 | - | $368.50M(+6.2%) | $1.40B(+0.6%) |
| Jun 2019 | - | $346.90M(+4.0%) | $1.39B(-2.5%) |
| Mar 2019 | - | $333.50M(-4.6%) | $1.43B(-0.2%) |
| Dec 2018 | $1.43B(-11.8%) | $349.50M(-3.1%) | $1.43B(-4.2%) |
| Sep 2018 | - | $360.80M(-5.7%) | $1.49B(-4.2%) |
| Jun 2018 | - | $382.80M(+13.9%) | $1.56B(-2.7%) |
| Mar 2018 | - | $336.00M(-18.4%) | $1.60B(-1.2%) |
| Dec 2017 | $1.62B(+6.1%) | $411.70M(-3.4%) | $1.62B(+2.0%) |
| Sep 2017 | - | $426.00M(+0.1%) | $1.59B(+2.7%) |
| Jun 2017 | - | $425.70M(+19.5%) | $1.55B(+2.2%) |
| Mar 2017 | - | $356.20M(-6.4%) | $1.51B(-0.8%) |
| Dec 2016 | $1.53B(+9.3%) | $380.60M(-1.0%) | $1.53B(+0.1%) |
| Sep 2016 | - | $384.60M(-2.0%) | $1.53B(+0.3%) |
| Jun 2016 | - | $392.60M(+6.6%) | $1.52B(+4.2%) |
| Mar 2016 | - | $368.30M(-3.0%) | $1.46B(+4.4%) |
| Dec 2015 | $1.40B(+20.1%) | $379.60M(+0.1%) | $1.40B(+3.6%) |
| Sep 2015 | - | $379.30M(+14.5%) | $1.35B(+7.2%) |
| Jun 2015 | - | $331.20M(+8.0%) | $1.26B(+3.9%) |
| Mar 2015 | - | $306.70M(-7.2%) | $1.21B(+4.1%) |
| Dec 2014 | $1.16B(+17.9%) | $330.56M(+14.3%) | $1.16B(+7.4%) |
| Sep 2014 | - | $289.15M(+1.8%) | $1.08B(+1.7%) |
| Jun 2014 | - | $284.09M(+9.8%) | $1.06B(+3.5%) |
| Mar 2014 | - | $258.80M(+3.4%) | $1.03B(+4.4%) |
| Dec 2013 | $985.86M(+23.7%) | $250.24M(-7.8%) | $985.86M(+4.7%) |
| Sep 2013 | - | $271.51M(+9.4%) | $941.77M(+6.4%) |
| Jun 2013 | - | $248.29M(+15.0%) | $884.76M(+6.3%) |
| Mar 2013 | - | $215.82M(+4.7%) | $832.42M(+4.5%) |
| Dec 2012 | $796.78M | $206.15M(-3.9%) | $796.78M(+4.8%) |
| Sep 2012 | - | $214.50M(+9.5%) | $760.48M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | $195.94M(+8.7%) | $725.04M(+4.8%) |
| Mar 2012 | - | $180.18M(+6.1%) | $691.69M(+5.7%) |
| Dec 2011 | $654.28M(+24.6%) | $169.85M(-5.1%) | $654.28M(+3.9%) |
| Sep 2011 | - | $179.07M(+10.1%) | $629.58M(+5.1%) |
| Jun 2011 | - | $162.59M(+13.9%) | $598.94M(+7.8%) |
| Mar 2011 | - | $142.77M(-1.6%) | $555.81M(+5.5%) |
| Dec 2010 | $525.23M(+61.8%) | $145.16M(-2.2%) | $527.03M(+10.4%) |
| Sep 2010 | - | $148.42M(+24.2%) | $477.30M(+15.5%) |
| Jun 2010 | - | $119.46M(+4.8%) | $413.34M(+12.4%) |
| Mar 2010 | - | $113.99M(+19.5%) | $367.78M(+13.3%) |
| Dec 2009 | $324.53M(+29.1%) | $95.43M(+13.0%) | $324.53M(+9.3%) |
| Sep 2009 | - | $84.46M(+14.3%) | $296.86M(+6.1%) |
| Jun 2009 | - | $73.90M(+4.5%) | $279.69M(+4.7%) |
| Mar 2009 | - | $70.74M(+4.4%) | $267.01M(+6.2%) |
| Dec 2008 | $251.43M(+33.3%) | $67.75M(+0.7%) | $251.43M(+6.0%) |
| Sep 2008 | - | $67.29M(+9.9%) | $237.22M(+6.5%) |
| Jun 2008 | - | $61.22M(+11.0%) | $222.81M(+7.1%) |
| Mar 2008 | - | $55.16M(+3.0%) | $208.07M(+10.3%) |
| Dec 2007 | $188.68M(+32.3%) | $53.54M(+1.3%) | $188.68M(+7.1%) |
| Sep 2007 | - | $52.88M(+13.7%) | $176.21M(+10.4%) |
| Jun 2007 | - | $46.49M(+30.0%) | $159.58M(+7.0%) |
| Mar 2007 | - | $35.77M(-12.9%) | $149.09M(+4.5%) |
| Dec 2006 | $142.60M(+37.6%) | $41.07M(+13.3%) | $142.60M(+11.4%) |
| Sep 2006 | - | $36.24M(+0.7%) | $128.02M(+5.5%) |
| Jun 2006 | - | $36.00M(+22.9%) | $121.35M(+8.1%) |
| Mar 2006 | - | $29.29M(+10.6%) | $112.23M(+8.3%) |
| Dec 2005 | $103.60M(+58.6%) | $26.49M(-10.4%) | $103.60M(+7.4%) |
| Sep 2005 | - | $29.58M(+10.0%) | $96.47M(+13.9%) |
| Jun 2005 | - | $26.88M(+30.2%) | $84.73M(+14.3%) |
| Mar 2005 | - | $20.65M(+6.7%) | $74.10M(+13.4%) |
| Dec 2004 | $65.34M(+40.3%) | $19.36M(+8.6%) | $65.34M(+12.1%) |
| Sep 2004 | - | $17.84M(+9.7%) | $58.29M(+8.5%) |
| Jun 2004 | - | $16.26M(+36.7%) | $53.74M(+8.7%) |
| Mar 2004 | - | $11.89M(-3.4%) | $49.44M(+6.2%) |
| Dec 2003 | $46.56M(+88.8%) | $12.31M(-7.3%) | $46.56M(+4.0%) |
| Sep 2003 | - | $13.28M(+11.1%) | $44.77M(+26.7%) |
| Jun 2003 | - | $11.96M(+32.7%) | $35.34M(+7.0%) |
| Mar 2003 | - | $9.01M(-14.4%) | $33.04M(+33.9%) |
| Dec 2002 | $24.66M(+850.4%) | $10.52M(+173.1%) | $24.66M(+64.3%) |
| Sep 2002 | - | $3.85M(-60.1%) | $15.01M(+29.2%) |
| Jun 2002 | - | $9.65M(+1417.5%) | $11.62M(+354.8%) |
| Mar 2002 | - | $636.00K(-27.1%) | $2.55M(-21.6%) |
| Dec 2001 | $2.60M(+655.5%) | $872.10K(+91.0%) | $3.26M(+32.3%) |
| Sep 2001 | - | $456.50K(-22.5%) | $2.46M(+14.1%) |
| Jun 2001 | - | $589.20K(-56.0%) | $2.16M(+25.7%) |
| Mar 2001 | - | $1.34M(+1621.6%) | $1.72M(+400.0%) |
| Dec 2000 | $343.50K(-135.7%) | $77.80K(-48.7%) | $343.50K(+29.3%) |
| Sep 2000 | - | $151.80K(+2.2%) | $265.70K(+133.3%) |
| Jun 2000 | - | $148.60K(-528.2%) | $113.90K(-428.2%) |
| Mar 2000 | - | -$34.70K | -$34.70K |
| Dec 1999 | -$963.50K | - | - |
FAQ
- What is United Therapeutics annual gross profit?
- What is the all time high annual gross profit for United Therapeutics?
- What is United Therapeutics annual gross profit year-on-year change?
- What is United Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for United Therapeutics?
- What is United Therapeutics quarterly gross profit year-on-year change?
- What is United Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for United Therapeutics?
- What is United Therapeutics TTM gross profit year-on-year change?
What is United Therapeutics annual gross profit?
The current annual gross profit of UTHR is $2.57B
What is the all time high annual gross profit for United Therapeutics?
United Therapeutics all-time high annual gross profit is $2.57B
What is United Therapeutics annual gross profit year-on-year change?
Over the past year, UTHR annual gross profit has changed by +$497.70M (+24.04%)
What is United Therapeutics quarterly gross profit?
The current quarterly gross profit of UTHR is $660.00M
What is the all time high quarterly gross profit for United Therapeutics?
United Therapeutics all-time high quarterly gross profit is $665.80M
What is United Therapeutics quarterly gross profit year-on-year change?
Over the past year, UTHR quarterly gross profit has changed by +$116.30M (+21.39%)
What is United Therapeutics TTM gross profit?
The current TTM gross profit of UTHR is $2.57B
What is the all time high TTM gross profit for United Therapeutics?
United Therapeutics all-time high TTM gross profit is $2.57B
What is United Therapeutics TTM gross profit year-on-year change?
Over the past year, UTHR TTM gross profit has changed by +$497.70M (+24.04%)